Generation of a Double KO Mouse by Simultaneous Targeting of the Neighboring Genes Tmem176a and Tmem176b Using CRISPR/Cas9: Key Steps from Design to Genotyping

Aurélie Lemoine; Gaëlle Chauveau-Le Friec; Francina Langa; Cédric Louvet

doi:10.1016/j.jgg.2016.04.004

Volume 43 Issue 5

May 2016

Turn off MathJax

Article Contents

Article Navigation > Journal of Genetics and Genomics > 2016 > 43(5): 329-340

PDF( 1324 KB)

Generation of a Double KO Mouse by Simultaneous Targeting of the Neighboring Genes Tmem176a and Tmem176b Using CRISPR/Cas9: Key Steps from Design to Genotyping

doi: 10.1016/j.jgg.2016.04.004

a
INSERM UMR 1064, Center for Research in Transplantation and Immunology, Université de Nantes, CHU Nantes, Institut de Transplantation Urologie Néphrologie (ITUN), Nantes 44093, France
b
Institut Pasteur, Plate-Forme Technologique Centre d'Ingénierie Génétique Murine, 25-28 rue du Dr. Roux, Paris 75724, France

More Information

Corresponding author: E-mail address: cedric.louvet@univ-nantes.fr (Cédric Louvet)
Received Date: 2016-01-05
Accepted Date: 2016-04-04
Rev Recd Date: 2016-03-26

Available Online: 2016-04-22

Publish Date: 2016-05-20

Abstract

Abstract

The CRISPR/Cas9 system has been tailored to a revolutionary genetic tool because of its remarkable simplicity and efficacy. While complex genome editing in the mouse since the 1990s has been dominated by the use of embryonic stem (ES) cells, CRISPR/Cas9 now offers a versatile and fast approach to precisely modify virtually any DNA regions directly in mouse zygotes. Yet, this relative simplicity does not preclude a conscientious preparatory work that is often neglected when initiating a project. Here, we describe the key steps leading to successful generation of a double knockout (KO) mouse by simultaneously targeting two homolog genes, Tmem176a and Tmem176b, which are located in the same genomic locus. Additionally, we show that similar efficiency can be obtained in a mixed genetic background or directly in the C57BL/6 inbred strain. Thus, presented as a detailed case study that should be helpful to the non-specialists, we focus on the genotyping strategy to anticipate the various possibilities.
- CRISPR/Cas9,
- C57BL/6,
- Double KO,
- Genotyping,
- NHEJ,
- Deletion,
- Inversion,
- Off-targets,
- Mosaicism

FullText(HTML)

References(34)

References

[1]	Ansai, S., Inohaya, K., Yoshiura, Y. et al. Design, evaluation, and screening methods for efficient targeted mutagenesis with transcription activator-like effector nucleases in medaka Dev. Growth Differ., 56 (2014),pp. 98-107
[2]	Behringer, R., Gerstentein, M., Vintersten, K. et al.
[3]	Bolukbasi, M.F., Gupta, A., Wolfe, S.A. Creating and evaluating accurate CRISPR-Cas9 scalpels for genomic surgery Nat. Methods, 13 (2015),pp. 41-50
[4]	Chenouard, V., Brusselle, L., Heslan, J.-M. et al. A rapid and cost-effective method for genotyping genome-edited animals: a heteroduplex mobility assay using microfluidic capillary electrophoresis J. Genet. Genomics, 43 (2016),pp. 341-348
[5]	Cho, S.W., Kim, S., Kim, Y. et al. Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases Genome Res., 24 (2014),pp. 132-141
[6]	Condamine, T., Le Texier, L., Howie, D. et al. Tmem176B and Tmem176A are associated with the immature state of dendritic cells J. Leukoc. Biol., 88 (2010),pp. 507-515
[7]	Cong, L., Ran, F.A., Cox, D. et al. Multiplex genome engineering using CRISPR/Cas systems Science, 339 (2013),pp. 819-823
[8]	Fu, Y., Sander, J.D., Reyon, D. et al. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs Nat. Biotechnol., 32 (2014),pp. 279-284
[9]	Hsu, P.D., Scott, D.A., Weinstein, J.A. et al. DNA targeting specificity of RNA-guided Cas9 nucleases Nat. Biotechnol., 31 (2013),pp. 827-832
[10]	Jinek, M., Chylinski, K., Fonfara, I. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity Science, 337 (2012),pp. 816-821
[11]	Kang, S., Tsai, L.T., Zhou, Y. et al. Identification of nuclear hormone receptor pathways causing insulin resistance by transcriptional and epigenomic analysis Nat. Cell Biol., 17 (2015),pp. 44-56
[12]	Kim, S., Kim, D., Cho, S.W. et al. Genome Res., 24 (2014),pp. 1012-1019
[13]	Kleinstiver, B.P., Pattanayak, V., Prew, M.S. et al. High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects Nature, 529 (2016),pp. 490-495
[14]	Kraft, K., Geuer, S., Will, A.J. et al. Deletions, inversions, duplications: engineering of structural variants using CRISPR/Cas in mice Cell Rep., 10 (2015),pp. 833-839
[15]	Louvet, C., Chiffoleau, E., Heslan, M. et al. Identification of a new member of the CD20/FcepsilonRIbeta family overexpressed in tolerated allografts Am. J. Transplant., 5 (2005),pp. 2143-2153
[16]	Maeda, Y., Ide, T., Koike, M. et al. GPHR is a novel anion channel critical for acidification and functions of the Golgi apparatus Nat. Cell Biol., 10 (2008),pp. 1135-1145
[17]	Menoret, S., De Cian, A., Tesson, L. et al. Homology-directed repair in rodent zygotes using Cas9 and TALEN engineered proteins Sci. Rep., 5 (2015),p. 14410
[18]	Menoret, S., Fontaniere, S., Jantz, D. et al. Generation of Rag1-knockout immunodeficient rats and mice using engineered meganucleases FASEB J., 27 (2013),pp. 703-711
[19]	Otsubo, T., Hida, Y., Ohga, N. et al. Identification of novel targets for antiangiogenic therapy by comparing the gene expressions of tumor and normal endothelial cells Cancer Sci., 105 (2014),pp. 560-567
[20]	Ramakrishna, S., Kwaku Dad, A.B., Beloor, J. et al. Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA Genome Res., 24 (2014),pp. 1020-1027
[21]	Ran, F.A., Cong, L., Yan, W.X. et al. Nature, 520 (2015),pp. 186-191
[22]	Ran, F.A., Hsu, P.D., Wright, J. et al. Genome engineering using the CRISPR-Cas9 system Nat. Protoc., 8 (2013),pp. 2281-2308
[23]	Ryu, S.H., Kim, K.H., Kim, H.B. et al. Oncogenic Ras-mediated downregulation of Clast1/LR8 is involved in Ras-mediated neoplastic transformation and tumorigenesis in NIH3T3 cells Cancer Sci., 101 (2010),pp. 1990-1996
[24]	Segovia, M., Louvet, C., Charnet, P. et al. Autologous dendritic cells prolong allograft survival through Tmem176b-dependent antigen cross-presentation Am. J. Transplant., 14 (2014),pp. 1021-1031
[25]	Slaymaker, I.M., Gao, L., Zetsche, B. et al. Rationally engineered Cas9 nucleases with improved specificity Science, 351 (2016),pp. 84-88
[26]	Stemmer, M., Thumberger, T., Del Sol Keyer, M. et al. CCTop: an intuitive, flexible and reliable CRISPR/Cas9 target prediction tool PLoS One, 10 (2015),p. e0124633
[27]	Tesson, L., Remy, S., Menoret, S. et al. Analysis by quantitative PCR of zygosity in genetically modified organisms Methods Mol. Biol., 597 (2010),pp. 277-285
[28]	Wang, H., Yang, H., Shivalila, C.S. et al. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering Cell, 153 (2013),pp. 910-918
[29]	Wang, L., Shao, Y., Guan, Y. et al. Sci. Rep., 5 (2015),p. 17517
[30]	Xiao, A., Wang, Z., Hu, Y. et al. Chromosomal deletions and inversions mediated by TALENs and CRISPR/Cas in zebrafish Nucleic Acids Res., 41 (2013),p. e141
[31]	Yano, M., Kawao, N., Tamura, Y. et al. A novel factor, Tmem176b, induced by activin-like kinase 2 signal promotes the differentiation of myoblasts into osteoblasts Exp. Clin. Endocrinol. Diabetes, 122 (2014),pp. 7-14
[32]	Yen, S.T., Zhang, M., Deng, J.M. et al. Somatic mosaicism and allele complexity induced by CRISPR/Cas9 RNA injections in mouse zygotes Dev. Biol., 393 (2014),pp. 3-9
[33]	Zhang, L., Jia, R., Palange, N.J. et al. Large genomic fragment deletions and insertions in mouse using CRISPR/Cas9 PLoS One, 10 (2015),p. e0120396
[34]	Zuccolo, J., Bau, J., Childs, S.J. et al. Phylogenetic analysis of the MS4A and TMEM176 gene families PLoS One, 5 (2010),p. e9369